JP2009527488A5 - - Google Patents

Download PDF

Info

Publication number
JP2009527488A5
JP2009527488A5 JP2008555480A JP2008555480A JP2009527488A5 JP 2009527488 A5 JP2009527488 A5 JP 2009527488A5 JP 2008555480 A JP2008555480 A JP 2008555480A JP 2008555480 A JP2008555480 A JP 2008555480A JP 2009527488 A5 JP2009527488 A5 JP 2009527488A5
Authority
JP
Japan
Prior art keywords
oral film
degradable
nicotine
film
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008555480A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009527488A (ja
JP5469868B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/062176 external-priority patent/WO2007095600A2/en
Publication of JP2009527488A publication Critical patent/JP2009527488A/ja
Publication of JP2009527488A5 publication Critical patent/JP2009527488A5/ja
Application granted granted Critical
Publication of JP5469868B2 publication Critical patent/JP5469868B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008555480A 2006-02-17 2007-02-15 分解可能な口腔フィルム Expired - Fee Related JP5469868B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77459206P 2006-02-17 2006-02-17
US60/774,592 2006-02-17
PCT/US2007/062176 WO2007095600A2 (en) 2006-02-17 2007-02-15 Disintegrable oral films

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013188331A Division JP2014037415A (ja) 2006-02-17 2013-09-11 分解可能な口腔フィルム

Publications (3)

Publication Number Publication Date
JP2009527488A JP2009527488A (ja) 2009-07-30
JP2009527488A5 true JP2009527488A5 (https=) 2010-04-02
JP5469868B2 JP5469868B2 (ja) 2014-04-16

Family

ID=38372253

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008555480A Expired - Fee Related JP5469868B2 (ja) 2006-02-17 2007-02-15 分解可能な口腔フィルム
JP2013188331A Pending JP2014037415A (ja) 2006-02-17 2013-09-11 分解可能な口腔フィルム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013188331A Pending JP2014037415A (ja) 2006-02-17 2013-09-11 分解可能な口腔フィルム

Country Status (10)

Country Link
US (3) US20070202057A1 (https=)
EP (1) EP1993509A2 (https=)
JP (2) JP5469868B2 (https=)
CN (1) CN101384249B (https=)
AU (1) AU2007214474B2 (https=)
BR (1) BRPI0708068A2 (https=)
CA (1) CA2640243C (https=)
MX (1) MX2008010548A (https=)
RU (1) RU2436565C2 (https=)
WO (1) WO2007095600A2 (https=)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1648421B1 (en) * 2003-07-24 2017-10-18 GlaxoSmithKline LLC Orally dissolving films
RU2436565C2 (ru) * 2006-02-17 2011-12-20 Новартис Аг Распадающиеся пероральные пленки
WO2009048522A1 (en) * 2007-10-11 2009-04-16 Richard Fuisz Smokeless tobacco product
AU2014202358B2 (en) * 2007-10-11 2016-06-16 Philip Morris Products S.A. Method for making a dosage
US9125434B2 (en) * 2007-10-11 2015-09-08 Philip Morris Products S.A. Smokeless tobacco product, smokeless tobacco product in the form of a sheet, extrudable tobacco composition, method for manufacturing a smokeless tobacco product, method for delivering super bioavailable nicotine contained in tobacco to a user, and packaged smokeless tobacco product sheet
US20090098192A1 (en) * 2007-10-11 2009-04-16 Fuisz Richard C Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same
BRPI0821608A2 (pt) * 2007-12-11 2015-09-29 Novartis Ag filmes de multizona
US8715715B2 (en) * 2008-11-03 2014-05-06 Nal Pharmaceuticals Ltd. Dosage form for insertion into the mouth
JP5284070B2 (ja) * 2008-12-12 2013-09-11 救急薬品工業株式会社 口腔内粘膜貼付製剤
US20100256197A1 (en) * 2009-04-02 2010-10-07 Silver Eagle Labs Nv, Llc Nicotine Dissolving Film With Or Without Menthol
US20100286587A1 (en) * 2009-05-07 2010-11-11 Yossi Gross Sublingual electrical drug delivery
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
HUE025446T2 (en) * 2009-12-30 2016-04-28 Novartis Ag Melt extruded nicotine thin strips
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US20130125907A1 (en) * 2011-11-17 2013-05-23 Michael Francis Dube Method for Producing Triethyl Citrate from Tobacco
CN103039688B (zh) 2012-01-20 2016-01-06 奥驰亚客户服务公司 口腔用产品
CN102754908B (zh) 2012-01-20 2015-06-10 奥驰亚客户服务公司 口腔用烟草产品
US9854831B2 (en) 2012-01-20 2018-01-02 Altria Client Services Llc Oral product
CN102754907B (zh) * 2012-01-20 2015-06-24 奥驰亚客户服务公司 口腔用产品
CA2895457A1 (en) * 2012-12-21 2014-06-26 Teva Pharmaceutical Industries Ltd. Oral transmucosal delivery of glatiramer acetate
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US9265284B2 (en) 2014-01-17 2016-02-23 R.J. Reynolds Tobacco Company Process for producing flavorants and related materials
US9044390B1 (en) 2014-04-17 2015-06-02 Gary J. Speier Pharmaceutical composition and method of manufacturing
US9186386B2 (en) 2014-04-17 2015-11-17 Gary J. Speier Pharmaceutical composition and method of manufacturing
AU2015299033B8 (en) * 2014-08-06 2021-01-28 Hexal Ag Method and device for determining the disintegration time of film-shaped pharmaceutical dosage forms
US10881133B2 (en) 2015-04-16 2021-01-05 R.J. Reynolds Tobacco Company Tobacco-derived cellulosic sugar
CN105055378B (zh) * 2015-08-19 2017-09-12 山东省药学科学院 一种盐酸美克洛嗪的口腔速释膜剂及其制备方法
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US10499684B2 (en) 2016-01-28 2019-12-10 R.J. Reynolds Tobacco Company Tobacco-derived flavorants
WO2018122095A1 (en) 2016-12-30 2018-07-05 Philip Morris Products S.A. Nicotine and cellulose containing sheet
US11091446B2 (en) 2017-03-24 2021-08-17 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines
CN107441068B (zh) * 2017-08-24 2021-02-26 正大制药（青岛）有限公司 一种盐酸可乐定口腔膜剂及其制备方法
KR101998288B1 (ko) * 2018-03-09 2019-07-09 (주)씨엘팜 무연 담배용 조성물 및 이를 포함하는 구강 용해 필름형 무연 담배
US12342847B2 (en) 2019-09-11 2025-07-01 Nicoventures Trading Limited Oral product with cellulosic flavor stabilizer
US12213510B2 (en) 2019-09-11 2025-02-04 Nicoventures Trading Limited Pouched products with enhanced flavor stability
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US12439952B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Moist oral compositions
US11883527B2 (en) 2019-12-09 2024-01-30 Nicoventures Trading Limited Oral composition and method of manufacture
US12520867B2 (en) 2019-12-09 2026-01-13 Nicoventures Trading Limited Buffered oral compositions
US12550928B2 (en) 2019-12-09 2026-02-17 Nicoventures Trading Limited Liquid oral composition
US12151023B2 (en) 2019-12-09 2024-11-26 Nicoventures Trading Limited Oral composition with beet material
US12171872B2 (en) 2019-12-09 2024-12-24 Nicoventures Trading Limited Oral compositions and methods of manufacture
US12137723B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Oral products with active ingredient combinations
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US12433321B2 (en) 2019-12-09 2025-10-07 Nicoventures Trading Limited Oral composition with beet material
EP4072516A1 (en) 2019-12-09 2022-10-19 Nicoventures Trading Limited Oral product comprising a cannabinoid
JP2023505351A (ja) 2019-12-09 2023-02-08 ニコベンチャーズ トレーディング リミテッド 口腔用組成物のための薬剤
US12439949B2 (en) 2019-12-09 2025-10-14 Nicoventures Trading Limited Oral compositions with reduced water activity
US12310959B2 (en) 2019-12-09 2025-05-27 Nicoventures Trading Limited Oral compositions with reduced water content
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11672862B2 (en) 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US12599160B2 (en) 2019-12-09 2026-04-14 Nicoventures Trading Limited Lipid-containing oral composition
US11617744B2 (en) 2019-12-09 2023-04-04 Nico Ventures Trading Limited Moist oral compositions
US11889856B2 (en) 2019-12-09 2024-02-06 Nicoventures Trading Limited Oral foam composition
US12491250B2 (en) 2019-12-09 2025-12-09 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
AU2021289162A1 (en) 2020-06-08 2023-02-09 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
US11839602B2 (en) 2020-11-25 2023-12-12 Nicoventures Trading Limited Oral cannabinoid product with lipid component
MX2023015529A (es) 2021-06-25 2024-03-05 Nicoventures Trading Ltd Productos orales y metodo de fabricacion.
KR20240036696A (ko) 2021-07-30 2024-03-20 니코벤처스 트레이딩 리미티드 미세결정질 셀룰로오스를 포함하는 에어로졸 발생 기재
CA3233375A1 (en) 2021-09-30 2023-04-06 Michael Zawadzki Oral product with a basic amine and an ion pairing agent
CN117398365B (zh) * 2022-07-08 2025-08-05 西安远大科创医药科技有限公司 一种吡仑帕奈口溶膜及其制备方法
WO2024037043A1 (zh) * 2023-04-28 2024-02-22 深圳华宝协同创新技术研究院有限公司 用于口腔粘膜的包含尼古丁的薄膜组合物
CN117205183A (zh) * 2023-09-28 2023-12-12 深圳华宝协同创新技术研究院有限公司 一种尼古丁口腔膜剂及其制备方法
US12594281B2 (en) 2024-03-15 2026-04-07 Emalex Biosciences, Inc. Pharmaceutical dosage forms and methods of use
US20260027045A1 (en) * 2024-07-23 2026-01-29 Aquestive Therapeutics, Inc. Methods of administering enhanced delivery epinephrine and prodrug compositions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2879695B2 (ja) * 1990-02-22 1999-04-05 日本曹達株式会社 口腔内粘膜付着性フィルム製剤
WO1996000072A1 (en) * 1994-06-23 1996-01-04 The Procter & Gamble Company Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US6596298B2 (en) * 1998-09-25 2003-07-22 Warner-Lambert Company Fast dissolving orally comsumable films
DE10018834A1 (de) * 2000-04-15 2001-10-25 Lohmann Therapie Syst Lts Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung
EP1389910A4 (en) 2001-04-20 2005-11-02 Lavipharm Lab Inc INTRABUCAL DISTRIBUTION OF NICOTINE INTENDED TO STOP SMOKING
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
US8765167B2 (en) * 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
DE10256775A1 (de) * 2002-12-05 2004-06-24 Lts Lohmann Therapie-Systeme Ag Filmförmige Zubereitungen zur transmucosalen Verabreichung von Nicotin, sowie Verfahren zu deren Herstellung
US20070059346A1 (en) * 2003-07-01 2007-03-15 Todd Maibach Film comprising therapeutic agents
EP1648421B1 (en) * 2003-07-24 2017-10-18 GlaxoSmithKline LLC Orally dissolving films
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
JP4413665B2 (ja) * 2004-03-19 2010-02-10 救急薬品工業株式会社 口腔内粘膜フィルム剤
RU2436565C2 (ru) * 2006-02-17 2011-12-20 Новартис Аг Распадающиеся пероральные пленки
SI2007362T1 (sl) * 2006-04-04 2018-12-31 Kg Acquisition Llc Peroralne odmerne oblike, ki vključujejo antitrombocitno sredstvo in inhibitor kisline
WO2008002567A2 (en) * 2006-06-27 2008-01-03 Alza Corporation Methods of treating conditions by sustained release administration of benzimidazole derivatives

Similar Documents

Publication Publication Date Title
JP2009527488A5 (https=)
RU2008137032A (ru) Распадающиеся пероральные пленки
US9937123B2 (en) Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents
US10398644B2 (en) Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
JP5283334B2 (ja) 経粘膜伝達用組成物材料
RU2010152012A (ru) Таблетируемые жевательные резинки
EP2364144A4 (en) PHARMACEUTICAL FORM FOR ADMINISTRATION THROUGH THE MOUTH
JP2016525572A5 (https=)
TWI829888B (zh) 應用於黏膜的醫藥劑型及其製造方法
JP2009529561A5 (https=)
RU2018121855A (ru) Сублингвальные и буккальные пленочные композиции
JP2005528427A5 (https=)
RU2011110715A (ru) Улучшение композиций или того, что имеет отношение к композициям
CN102961365B (zh) 硫酸特布他林口腔速溶膜及其制备方法
JP2008542299A5 (https=)
CN116801870A (zh) 固体药物组合物及其生产方法
CN103263402A (zh) 一种无需饮水的口服药物组合物及其制备方法
CN102028672A (zh) 微孔海绵状药膜制剂及其制备方法
TW200413035A (en) Film-like preparation for transmucosal administration of nicotine, and processes for their manufacture
JP2007529564A5 (https=)
CN103349657B (zh) 利培酮膜状制剂
JP2018526420A5 (https=)
CN101380313B (zh) 法莫替丁高密度型胃滞留渗透泵控释制剂及其制备方法
JP2004099591A (ja) 点鼻剤組成物
JP2008520696A5 (https=)